BioCentury
ARTICLE | Financial News

Freeline Therapeutics completes venture financing

December 14, 2015 8:00 AM UTC

Freeline Therapeutics, London, U.K. Business: Gene/Cell therapy, Hematology Date completed: 2015-12-10 Type: Venture financing Raised: L25 million ($37.7 million) Investor: Syncona Partners LLP ...